Programmed Cell Death Ligand 1 Expression in Primary Central Nervous System Lymphomas: A Clinicopathological Study

被引：31

作者：

Hayano, Azusa ^{[1
]}

Komohara, Yoshihiro ^{[2
]}

Takashima, Yasuo ^{[1
]}

Takeya, Hiroto ^{[2
]}

Homma, Jumpei ^{[3
]}

Fukai, Junya ^{[5
]}

Iwadate, Yasuo ^{[6
]}

Kajiwara, Koji ^{[7
]}

Ishizawa, Shin ^{[4
]}

Hondoh, Hiroaki ^{[3
]}

Yamanaka, Ryuya ^{[1
]}

机构：

[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Lab Mol Target Therapy Canc, Kyoto, Japan

[2] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto, Japan

[3] Toyama Prefectural Cent Hosp, Dept Neurosurg, Toyama, Japan

[4] Toyama Prefectural Cent Hosp, Dept Pathol, Toyama, Japan

[5] Wakayama Med Univ, Dept Neurol Surg, Sch Med, Wakayama, Japan

[6] Chiba Univ, Grad Sch Med Sci, Dept Neurosurg, Chiba, Japan

[7] Yamaguchi Univ, Grad Sch Med Sci, Dept Neurosurg, Ube, Yamaguchi, Japan

来源：

ANTICANCER RESEARCH | 2017年 / 37卷 / 10期

基金：

日本学术振兴会;

关键词：

Primary central nervous system lymphoma; checkpoint inhibitor; diffuse large B cell lymphoma; PD-L1; tumor microenvironment; tumor-infiltrating immune cell; WHOLE-BRAIN RADIOTHERAPY; LUNG-CANCER; ANTI-PD-L1; ANTIBODY; LYMPHOCYTE SUBSETS; HODGKINS LYMPHOMA; B7-H1; EXPRESSION; PD-1; BLOCKADE; NIVOLUMAB; SAFETY; SURVIVAL;

D O I：

10.21873/anticanres.12001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background/Aim: Programmed cell death ligand 1 (PD-L1)/programmed cell death 1 (PD-1) have been shown to predict response to PD-L1/PD-1-targeted therapy. We analyzed PD-L1 expression in primary central nervous system lymphomas (PCNSLs). Materials and Methods: PD-L1 protein and mRNA expression were evaluated in 64 PCNSL tissue samples. IFN-gamma, IL-10, CD4, and CD8 mRNA expression was also evaluated. Results: PD-L1 protein was detected in tumor cells in 2 (4.1%) cases and in tumor microenvironments in 25 (52%) cases. PD-L1 mRNA positively correlated with IFN-gamma (p=0.0024) and CD4 (p=0.0005) mRNA expression. IFN-gamma mRNA positively correlated with CD8 mRNA expression (p=0.0001). Furthermore, tumor cell PD-L1 expression correlated positively with overall survival (p=0.0177), whereas microenvironmental PD-L1 expression exhibited an insignificant negative trend with overall survival (p=0.188). Conclusion: PD-L1 was expressed on both tumor and/or tumor-infiltrating immune cells in PCNSL. The biological roles of this marker warrant further investigation.

引用

页码：5655 / 5666

页数：12

共 58 条

[1] Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model [J].

Abrey, Lauren E. ;

Ben-Porat, Leah ;

Panageas, Katherine S. ;

Yahalom, Joachim ;

Berkey, Brian ;

Curran, Walter ;

Schultz, Christopher ;

Leibel, Steven ;

Nelson, Diana ;

Mehta, Minesh ;

DeAngelis, Lisa M. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (36) :5711-5715

[2] Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma [J].

Ahearne, Matthew J. ;

Bhuller, Kaljit ;

Hew, Roger ;

Ibrahim, Hazem ;

Naresh, Kikkeri ;

Wagner, Simon D. .

VIRCHOWS ARCHIV, 2014, 465 (03) :351-358

[3] Programmed Death Ligand 1 Is Expressed by Non-Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells [J].

Andorsky, David J. ;

Yamada, Reiko E. ;

Said, Jonathan ;

Pinkus, Geraldine S. ;

Betting, David J. ;

Timmerman, John M. .

CLINICAL CANCER RESEARCH, 2011, 17 (13) :4232-4244

[4] PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].

Ansell, Stephen M. ;

Lesokhin, Alexander M. ;

Borrello, Ivan ;

Halwani, Ahmad ;

Scott, Emma C. ;

Gutierrez, Martin ;

Schuster, Stephen J. ;

Millenson, Michael M. ;

Cattry, Deepika ;

Freeman, Gordon J. ;

Rodig, Scott J. ;

Chapuy, Bjoern ;

Ligon, Azra H. ;

Zhu, Lili ;

Grosso, Joseph F. ;

Kim, Su Young ;

Timmerman, John M. ;

Shipp, Margaret A. ;

Armand, Philippe .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319

[5] Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial [J].

Armand, Philippe ;

Nagler, Arnon ;

Weller, Edie A. ;

Devine, Steven M. ;

Avigan, David E. ;

Chen, Yi-Bin ;

Kaminski, Mark S. ;

Holland, H. Kent ;

Winter, Jane N. ;

Mason, James R. ;

Fay, Joseph W. ;

Rizzieri, David A. ;

Hosing, Chitra M. ;

Ball, Edward D. ;

Uberti, Joseph P. ;

Lazarus, Hillard M. ;

Mapara, Markus Y. ;

Gregory, Stephanie A. ;

Timmerman, John M. ;

Andorsky, David ;

Or, Reuven ;

Waller, Edmund K. ;

Rotem-Yehudar, Rinat ;

Gordon, Leo I. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (33) :4199-4206

[6] Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor Types [J].

Ascierto, Paolo A. ;

Kalos, Michael ;

Schaer, David A. ;

Callahan, Margaret K. ;

Wolchok, Jedd D. .

CLINICAL CANCER RESEARCH, 2013, 19 (05) :1009-1020

[7] Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies [J].

Berger, Raanan ;

Rotem-Yehudar, Rinat ;

Slama, Gideon ;

Landes, Shimon ;

Kneller, Abraham ;

Leiba, Merav ;

Koren-Michowitz, Maya ;

Shimoni, Avichai ;

Nagler, Arnon .

CLINICAL CANCER RESEARCH, 2008, 14 (10) :3044-3051

[8] PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL) [J].

Berghoff, Anna Sophie ;

Ricken, Gerda ;

Widhalm, Georg ;

Rajky, Orsolya ;

Hainfellner, Johannes A. ;

Birner, Peter ;

Raderer, Markus ;

Preusser, Matthias .

CLINICAL NEUROPATHOLOGY, 2014, 33 (01) :42-49

[9] Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm [J].

Biswas, Subhra K. ;

Mantovani, Alberto .

NATURE IMMUNOLOGY, 2010, 11 (10) :889-896

[10] Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer [J].

Bostrom, Minna M. ;

Irjala, Heikki ;

Mirtti, Tuomas ;

Taimen, Pekka ;

Kauko, Tommi ;

Algars, Annika ;

Jalkanen, Sirpa ;

Bostrom, Peter J. .

PLOS ONE, 2015, 10 (07)

← 1 2 3 4 5 6 →